Miller Matthew P has filed 7 Form 4s with the SEC that we hold, all for Starling Oncology, Inc. (TOI), as Chief Operating Officer. Across all of them we count 1 purchase worth $70.0K and 1 sale worth $1.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 73,684 shares of Starling Oncology, Inc. worth $70.0K, dated 2022-12-16. The first filing on our record is dated 2022-03-23 and the latest 2023-03-21.
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-11-15 | S, sale reported on Form 4 | 577 | $1.2K | 2022-11-22 |
| 2022-12-16 | P, purchase reported on Form 4 | 73,684 | $70.0K | 2022-12-20 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1915822) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms
No password to create and no card required. We store your email address and nothing else.